register

News & Trends - MedTech & Diagnostics

Australia’s largest cancer care provider extends international footprint

Health Industry Hub | August 23, 2023 |

MedTech & Diagnostics News: Australia’s largest integrated cancer care provider, Icon Group, is joining forces with Nuffield Health, United Kingdom’s largest healthcare charity. Backed by the strategic investment of private equity firm EQT, this dynamic partnership is poised to redefine the standards of oncology care and deliver unparalleled patient experience.

Icon Group and Nuffield Health are embarking on a visionary venture aimed at providing top-tier oncology care that seamlessly combines clinical expertise with a world-class patient journey. This transformative alliance is set to kick off with a focus on advancing radiotherapy services – a pivotal aspect of modern cancer treatment.

Nuffield Health holds a distinguished record as the sole UK-wide independent hospital provider with all of its hospitals earning ‘Good’ or ‘Outstanding’ ratings from UK regulators. Their mission to deliver exceptional care within local communities mirrors Icon Group’s commitment to raising the bar for cancer treatment on a global scale. Having expanded its footprint to New Zealand, Singapore, Mainland China, and Hong Kong, Icon Group brings a wealth of experience and innovation to this collaboration.

Wouter Van den Brande, Chief Strategy and Development Officer of Nuffield Health, expressed the excitement surrounding the partnership. He said “Icon Group’s clinical expertise, values and investment strategy align closely with ours. We have a shared vision to deliver the best clinical outcomes to as many people as possible. We are working in partnership with Icon to explore how, together, we can meet the rising demand for cancer care in the UK. Our initial focus will be on how our patients can benefit from Icon’s world-leading expertise in radiotherapy.”

Mark Middleton, CEO of Icon Group, echoed the enthusiasm for the collaboration, saying “We’re thrilled to partner with Nuffield Health and work together to help tackle the UK’s cancer burden and improve access to radiotherapy, across the region. Patient focused and clinician led, this partnership prioritises personalised treatment plans and access to cutting edge treatments to deliver the highest standards of care and improved outcome for patients.”

In the forthcoming months, Icon Group and Nuffield Health will join forces to usher in the inaugural phase of their transformative partnership, with details of the collaboration soon to be unveiled.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


Digital & Innovation

Meta finally admits to exploiting Aussie data for AI training: Call for privacy law reforms

Meta finally admits to exploiting Aussie data for AI training: Call for privacy law reforms

Health Industry Hub | September 13, 2024 |

Digital & Innovation: Facebook uses photos, posts and data from its adult Australian users to train AI models, Meta’s global […]

More


News & Trends - MedTech & Diagnostics

Policymakers undergo diabetes health check as push for equitable access to medical technologies escalates

Policymakers undergo diabetes health check as push for equitable access to medical technologies escalates

Health Industry Hub | September 13, 2024 |

MedTech News: Policymakers at Parliament House underwent a comprehensive health check yesterday, including assessments for HbA1c, cholesterol, blood pressure, and […]

More


News & Trends - Pharmaceuticals

Diabetes drugs underused in Australia despite proven benefits, study reveals

Diabetes drugs underused in Australia despite proven benefits, study reveals

Health Industry Hub | September 13, 2024 |

Pharma News: A new analysis has revealed that more Australians with type 2 diabetes should have access to potentially lifesaving […]

More


News & Trends - MedTech & Diagnostics

Landmark funding to expand genomic testing and precision medicine access for Victorian cancer patients

Landmark funding to expand genomic testing and precision medicine access for Victorian cancer patients

Health Industry Hub | September 13, 2024 |

Diagnostics News: A landmark funding contribution will establish an advanced genomic testing program in Victoria, aiming to deliver personalised, precision […]

More


This content is copyright protected. Please subscribe to gain access.